De behandeling met 5- (Pentafluorbenzoylamino) fluoresceïne werd gestaakt. Zie 233790

Fluorescent Nanodiamond in DI water, < 1ppm NV

NDNV20nmMd10ml

10 mL

Fluorescent Nanodiamond in DI water, ~3ppm NV

NDNV70nmHi10ml

10 mL

Ligation Buffer

LB001

1.4 mL

BioCoupler® x 12

BC12

12 Each

Recombinant Common timothy PHLPIV/Phl p 4 Protein, N-His

YZZ03001

100 μg

NP (4-hydroxy-3-nitrophenylacetate)

NP-BSA-03Low – 10 mg

10 mg

NP (4-hydroxy-3-nitrophenylacetate)

NP-BSA-03High – 10 mg

10 mg

ExactaCruz® Pipette Tip Reload System, 50-1250 μl, case

sc-201714

80 Racks/Case

HTLV2 env 801 Antibody

GWB-75D477

0.025 mg

HTLV-2 env 801 (Human T Cell Leukemia Virus)

MBS600394-01

0.1 mg

HTLV-2 env 802 (Human T Cell Leukemia Virus)

MBS603963-01

0.1 mg

HTLV-2 env 802 Recombinant (Human T Cell Leukemia Virus)

MBS636508-01

0.05 mg

Recombinant Human RET Protein (V804M, G810S, GST Tag), Active

MBS518016-01

0.01 mg

Poly (acrylic acid) (Mv 8000000)

TCL-00897-01

100 mg

HTLV-2 env 801 (Human T Cell Leukemia Virus)

H7951-11

100 µg

HTLV-2 env 802 Recombinant (Human T Cell Leukemia Virus)

H7951-20

50 µg